公开(公告)号：US20220361812A1

公开(公告)日：2022-11-17

申请号：US17736380

申请日：2022-05-04

Applicant: Insulet Corporation

Inventor： Rangarajan NARAYANASWAMI ,  Yibin ZHENG ,  Jay JANTZ ,  Joon Bok LEE

IPC: A61B5/00 ,  G16H20/17 ,  G16H10/60 ,  G16H50/20 ,  G16H50/50 ,  A61M5/172 ,  A61B5/145

Abstract: The disclosed embodiments are directed to systems and methods for providing optimized, individualized bolus dosing of insulin based on a macronutrient profile of meals ingested by the patient. Optimized bolus dosing may be provided by varying the overall quantity of insulin delivered in the post-prandial window, as well as the split between a portion of the insulin delivered immediately after the meal and a portion of the insulin delivered later in the post-prandial window, based on an analysis of the macronutrient profile of the meal and the behavior of the blood glucose trace of the patient from past meals.

公开(公告)号：US20220355030A1

公开(公告)日：2022-11-10

申请号：US17736414

申请日：2022-05-04

Applicant: Insulet Corporation

Inventor： Rangarajan NARAYANASWAMI ,  Jay JANTZ ,  Steven LOWEN ,  Albert CHANG ,  Oussama KARKACH

IPC: A61M5/172 ,  G16H20/17

Abstract: The disclosed embodiments are directed to an automatic drug delivery (ADD) system device configured to provide bolus dosing of insulin. The embodiments include a system and method for providing an improved meal input interface for the user as well as methods for the use of the information provided by the user to both improve the post-prandial bolus dosing of insulin and to advise the user on meals that will lead to improved blood glucose control for the user.

公开(公告)号：US20220273873A1

公开(公告)日：2022-09-01

申请号：US17668509

申请日：2022-02-10

Applicant: Insulet Corporation

Inventor： Joshua WILLIAMS ,  Pauline TANDON ,  Mark FIELD ,  Jay JANTZ ,  Steve LOWEN ,  Rangarajan NARAYANASWAMI

IPC: A61M5/172 ,  G16H20/17 ,  G16H50/20 ,  G16H50/30

Abstract: The provided examples of systems, devices and techniques improve systems and methods for keeping users of automatic drug delivery systems engaged and assisting with the optimal use of the drug delivery system. The automatic drug delivery system may include a drug delivery device and a controller. Through the use of an attrition prevention engine in a cloud-based services system that cooperates with an attrition prevention application executing on the controller of the drug delivery device, notifications that include instructions for adjusting operation of the drug delivery device as well as offer assistance to the patient to optimize performance of the drug delivery system for the patient may be provided. Optimizing the performance of the drug delivery system has been shown to prevent attrition of patients from using the drug delivery system.